Hepatoprotective  ||| S:0 E:17 ||| NNP
Effects  ||| S:17 E:25 ||| NNPS
of  ||| S:25 E:28 ||| IN
Traditional  ||| S:28 E:40 ||| NNP
Chinese  ||| S:40 E:48 ||| NNP
Medicine  ||| S:48 E:57 ||| NNP
on  ||| S:57 E:60 ||| IN
Liver  ||| S:60 E:66 ||| NNP
Fibrosis  ||| S:66 E:75 ||| NNP
from  ||| S:75 E:80 ||| IN
Ethanol  ||| S:80 E:88 ||| NNP
Administration  ||| S:88 E:103 ||| NNP
following  ||| S:103 E:113 ||| VBG
Partial  ||| S:113 E:121 ||| NNP
Hepatectomy  ||| S:121 E:133 ||| NNP
The  ||| S:133 E:137 ||| DT
aim  ||| S:137 E:141 ||| NN
of  ||| S:141 E:144 ||| IN
this  ||| S:144 E:149 ||| DT
study  ||| S:149 E:155 ||| NN
was  ||| S:155 E:159 ||| VBD
to  ||| S:159 E:162 ||| TO
establish  ||| S:162 E:172 ||| VB
the  ||| S:172 E:176 ||| DT
effective  ||| S:176 E:186 ||| JJ
hepatoprotective  ||| S:186 E:203 ||| JJ
properties  ||| S:203 E:214 ||| NNS
of  ||| S:214 E:217 ||| IN
traditional  ||| S:217 E:229 ||| JJ
Chinese  ||| S:229 E:237 ||| JJ
medicines  ||| S:237 E:247 ||| NNS
( ||| S:247 E:248 ||| -LRB-
TCMs ||| S:248 E:252 ||| NNP
)  ||| S:252 E:254 ||| -RRB-
in  ||| S:254 E:257 ||| IN
fibrotic  ||| S:257 E:266 ||| JJ
rat  ||| S:266 E:270 ||| NN
liver  ||| S:270 E:276 ||| NN
regeneration  ||| S:276 E:289 ||| NN
after  ||| S:289 E:295 ||| IN
partial  ||| S:295 E:303 ||| JJ
hepatectomy  ||| S:303 E:315 ||| NNS
( ||| S:315 E:316 ||| -LRB-
PHx ||| S:316 E:319 ||| NNP
) ||| S:319 E:320 ||| -RRB-
.  ||| S:320 E:322 ||| .
Fibrosis  ||| S:322 E:331 ||| NNP
was  ||| S:331 E:335 ||| VBD
induced  ||| S:335 E:343 ||| VBN
in  ||| S:343 E:346 ||| IN
rats  ||| S:346 E:351 ||| NNS
by  ||| S:351 E:354 ||| IN
ethanol  ||| S:354 E:362 ||| NNS
( ||| S:362 E:363 ||| -LRB-
EtOH ||| S:363 E:367 ||| NNP
,  ||| S:367 E:369 ||| ,
5  ||| S:369 E:371 ||| CD
ml ||| S:371 E:373 ||| CD
/ ||| S:373 E:374 ||| CD
kg ||| S:374 E:376 ||| CD
)  ||| S:376 E:378 ||| -RRB-
administration  ||| S:378 E:393 ||| NN
for  ||| S:393 E:397 ||| IN
6 ||| S:397 E:398 ||| CD
,  ||| S:398 E:400 ||| ,
24 ||| S:400 E:402 ||| CD
,  ||| S:402 E:404 ||| ,
72 ||| S:404 E:406 ||| CD
,  ||| S:406 E:408 ||| ,
and  ||| S:408 E:412 ||| CC
168  ||| S:412 E:416 ||| CD
h ||| S:416 E:417 ||| NNS
.  ||| S:417 E:419 ||| .
The  ||| S:419 E:423 ||| DT
rats  ||| S:423 E:428 ||| NNS
were  ||| S:428 E:433 ||| VBD
then  ||| S:433 E:438 ||| RB
fed  ||| S:438 E:442 ||| VBN
four  ||| S:442 E:447 ||| CD
TCMs  ||| S:447 E:452 ||| NNS
( ||| S:452 E:453 ||| -LRB-
1  ||| S:453 E:455 ||| CD
g ||| S:455 E:456 ||| CD
/ ||| S:456 E:457 ||| CD
kg ||| S:457 E:459 ||| CD
/ ||| S:459 E:460 ||| CD
day ||| S:460 E:463 ||| NN
,  ||| S:463 E:465 ||| ,
Codonopsis  ||| S:465 E:476 ||| NNP
pilosula  ||| S:476 E:485 ||| NNS
( ||| S:485 E:486 ||| -LRB-
CP ||| S:486 E:488 ||| NNP
) ||| S:488 E:489 ||| -RRB-
,  ||| S:489 E:491 ||| ,
Salvia  ||| S:491 E:498 ||| FW
miltorrhiza  ||| S:498 E:510 ||| FW
Bunge  ||| S:510 E:516 ||| FW
( ||| S:516 E:517 ||| -LRB-
SMB ||| S:517 E:520 ||| NNP
) ||| S:520 E:521 ||| -RRB-
,  ||| S:521 E:523 ||| ,
Bupleurum  ||| S:523 E:533 ||| NNP
kasi  ||| S:533 E:538 ||| NNS
( ||| S:538 E:539 ||| -LRB-
BK ||| S:539 E:541 ||| NNP
) ||| S:541 E:542 ||| -RRB-
,  ||| S:542 E:544 ||| ,
and  ||| S:544 E:548 ||| CC
Elephantopus  ||| S:548 E:561 ||| NNP
scaber  ||| S:561 E:568 ||| VBD
L  ||| S:568 E:570 ||| NNP
( ||| S:570 E:571 ||| -LRB-
ESL ||| S:571 E:574 ||| NNP
) ||| S:574 E:575 ||| -RRB-
)  ||| S:575 E:577 ||| -RRB-
to  ||| S:577 E:580 ||| TO
Spraque-Dawley  ||| S:580 E:595 ||| JJ
rats  ||| S:595 E:600 ||| NNS
for  ||| S:600 E:604 ||| IN
6 ||| S:604 E:605 ||| CD
,  ||| S:605 E:607 ||| ,
24 ||| S:607 E:609 ||| CD
,  ||| S:609 E:611 ||| ,
72  ||| S:611 E:614 ||| CD
and  ||| S:614 E:618 ||| CC
168  ||| S:618 E:622 ||| CD
h ||| S:622 E:623 ||| NN
,  ||| S:623 E:625 ||| ,
respectively ||| S:625 E:637 ||| RB
.  ||| S:637 E:639 ||| .
Surgical  ||| S:639 E:648 ||| JJ
70 ||| S:648 E:650 ||| CD
%  ||| S:650 E:652 ||| NN
cirrhotic  ||| S:652 E:662 ||| VBZ
fibrosis  ||| S:662 E:671 ||| JJ
PHx  ||| S:671 E:675 ||| NN
was  ||| S:675 E:679 ||| VBD
then  ||| S:679 E:684 ||| RB
conducted  ||| S:684 E:694 ||| VBN
at  ||| S:694 E:697 ||| IN
6 ||| S:697 E:698 ||| CD
,  ||| S:698 E:700 ||| ,
24 ||| S:700 E:702 ||| CD
,  ||| S:702 E:704 ||| ,
72 ||| S:704 E:706 ||| CD
,  ||| S:706 E:708 ||| ,
and  ||| S:708 E:712 ||| CC
168  ||| S:712 E:716 ||| CD
h ||| S:716 E:717 ||| NNS
.  ||| S:717 E:719 ||| .
The  ||| S:719 E:723 ||| DT
effects  ||| S:723 E:731 ||| NNS
on  ||| S:731 E:734 ||| IN
liver  ||| S:734 E:740 ||| JJ
regeneration  ||| S:740 E:753 ||| NN
were  ||| S:753 E:758 ||| VBD
examined  ||| S:758 E:767 ||| VBN
to  ||| S:767 E:770 ||| TO
estimate  ||| S:770 E:779 ||| VB
and  ||| S:779 E:783 ||| CC
measure  ||| S:783 E:791 ||| NN
hepatocyte  ||| S:791 E:802 ||| NN
growth  ||| S:802 E:809 ||| NN
factor  ||| S:809 E:816 ||| NN
( ||| S:816 E:817 ||| -LRB-
HGF ||| S:817 E:820 ||| NNP
) ||| S:820 E:821 ||| -RRB-
,  ||| S:821 E:823 ||| ,
focal  ||| S:823 E:829 ||| FW
adhesion  ||| S:829 E:838 ||| FW
kinase  ||| S:838 E:845 ||| FW
( ||| S:845 E:846 ||| -LRB-
FAK ||| S:846 E:849 ||| NNP
) ||| S:849 E:850 ||| -RRB-
,  ||| S:850 E:852 ||| ,
Cyclin  ||| S:852 E:859 ||| NNP
D1 ||| S:859 E:861 ||| NNP
,  ||| S:861 E:863 ||| ,
Cyclin  ||| S:863 E:870 ||| NNP
E ||| S:870 E:871 ||| NNP
,  ||| S:871 E:873 ||| ,
and  ||| S:873 E:877 ||| CC
retinoblastoma  ||| S:877 E:892 ||| NN
protein  ||| S:892 E:900 ||| NN
( ||| S:900 E:901 ||| -LRB-
pRb ||| S:901 E:904 ||| NNP
)  ||| S:904 E:906 ||| -RRB-
protein  ||| S:906 E:914 ||| NN
expression  ||| S:914 E:925 ||| NN
using  ||| S:925 E:931 ||| VBG
Western  ||| S:931 E:939 ||| JJ
blotting  ||| S:939 E:948 ||| JJ
analysis ||| S:948 E:956 ||| NN
.  ||| S:956 E:958 ||| .
Cyclin  ||| S:958 E:965 ||| NNP
D1 ||| S:965 E:967 ||| NNP
,  ||| S:967 E:969 ||| ,
matrix  ||| S:969 E:976 ||| FW
metalloproteinase  ||| S:976 E:994 ||| FW
( ||| S:994 E:995 ||| -LRB-
MMP ||| S:995 E:998 ||| NNP
) ||| S:998 E:999 ||| -RRB-
-2 ||| S:999 E:1001 ||| NNP
,  ||| S:1001 E:1003 ||| ,
MMP-9 ||| S:1003 E:1008 ||| NNP
,  ||| S:1008 E:1010 ||| ,
tissue  ||| S:1010 E:1017 ||| NN
inhibitors  ||| S:1017 E:1028 ||| NN
of  ||| S:1028 E:1031 ||| IN
metalloproteinase  ||| S:1031 E:1049 ||| NNS
( ||| S:1049 E:1050 ||| -LRB-
TIMP ||| S:1050 E:1054 ||| NNP
) ||| S:1054 E:1055 ||| -RRB-
-1 ||| S:1055 E:1057 ||| NNP
,  ||| S:1057 E:1059 ||| ,
TIMP-2  ||| S:1059 E:1066 ||| NNP
and  ||| S:1066 E:1070 ||| CC
TIMP-3  ||| S:1070 E:1077 ||| CD
mRNA  ||| S:1077 E:1082 ||| NN
by  ||| S:1082 E:1085 ||| IN
Reverse  ||| S:1085 E:1093 ||| NNP
transcription  ||| S:1093 E:1107 ||| VBD
polymerase  ||| S:1107 E:1118 ||| JJ
chain  ||| S:1118 E:1124 ||| NN
reaction  ||| S:1124 E:1133 ||| NN
( ||| S:1133 E:1134 ||| -LRB-
RT-PCR ||| S:1134 E:1140 ||| NNP
)  ||| S:1140 E:1142 ||| -RRB-
were  ||| S:1142 E:1147 ||| VBD
analyzed  ||| S:1147 E:1156 ||| VBN
in  ||| S:1156 E:1159 ||| IN
cirrhotic  ||| S:1159 E:1169 ||| JJ
fibrosis  ||| S:1169 E:1178 ||| JJ
rats ||| S:1178 E:1182 ||| NNS
.  ||| S:1182 E:1184 ||| .
Transforming  ||| S:1184 E:1197 ||| VBG
growth  ||| S:1197 E:1204 ||| NN
factor-β1  ||| S:1204 E:1214 ||| NNP
( ||| S:1214 E:1215 ||| -LRB-
TGF-β1 ||| S:1215 E:1221 ||| NNP
) ||| S:1221 E:1222 ||| -RRB-
,  ||| S:1222 E:1224 ||| ,
Cyclin  ||| S:1224 E:1231 ||| NNP
D1 ||| S:1231 E:1233 ||| NNP
,  ||| S:1233 E:1235 ||| ,
Cyclin  ||| S:1235 E:1242 ||| NNP
E ||| S:1242 E:1243 ||| NNP
,  ||| S:1243 E:1245 ||| ,
pRb  ||| S:1245 E:1249 ||| JJ
and  ||| S:1249 E:1253 ||| CC
E2F  ||| S:1253 E:1257 ||| CD
mRNA  ||| S:1257 E:1262 ||| JJ
expression  ||| S:1262 E:1273 ||| NN
levels  ||| S:1273 E:1280 ||| NNS
were  ||| S:1280 E:1285 ||| VBD
determined  ||| S:1285 E:1296 ||| VBN
in  ||| S:1296 E:1299 ||| IN
fibrotic  ||| S:1299 E:1308 ||| JJ
rats  ||| S:1308 E:1313 ||| NNS
following  ||| S:1313 E:1323 ||| VBG
PHx  ||| S:1323 E:1327 ||| JJ
using  ||| S:1327 E:1333 ||| VBG
RT-PCR ||| S:1333 E:1339 ||| JJ
.  ||| S:1339 E:1341 ||| .
We  ||| S:1341 E:1344 ||| PRP
found  ||| S:1344 E:1350 ||| VBD
elevated  ||| S:1350 E:1359 ||| FW
glutamyl  ||| S:1359 E:1368 ||| FW
oxaloacetic  ||| S:1368 E:1380 ||| FW
transaminase  ||| S:1380 E:1393 ||| FW
( ||| S:1393 E:1394 ||| -LRB-
GOT ||| S:1394 E:1397 ||| NNP
) ||| S:1397 E:1398 ||| -RRB-
,  ||| S:1398 E:1400 ||| ,
glutamyl  ||| S:1400 E:1409 ||| FW
pyrubic  ||| S:1409 E:1417 ||| FW
transaminase  ||| S:1417 E:1430 ||| FW
( ||| S:1430 E:1431 ||| -LRB-
GPT ||| S:1431 E:1434 ||| NNP
) ||| S:1434 E:1435 ||| -RRB-
,  ||| S:1435 E:1437 ||| ,
alkaline  ||| S:1437 E:1446 ||| FW
phosphatase  ||| S:1446 E:1458 ||| FW
( ||| S:1458 E:1459 ||| -LRB-
ALP ||| S:1459 E:1462 ||| NNP
) ||| S:1462 E:1463 ||| -RRB-
,  ||| S:1463 E:1465 ||| ,
gammaglutamyl  ||| S:1465 E:1479 ||| FW
transpeptidase  ||| S:1479 E:1494 ||| FW
( ||| S:1494 E:1495 ||| -LRB-
γ-GT ||| S:1495 E:1499 ||| NNP
) ||| S:1499 E:1500 ||| -RRB-
,  ||| S:1500 E:1502 ||| ,
glutathione  ||| S:1502 E:1514 ||| NNS
( ||| S:1514 E:1515 ||| -LRB-
GSH ||| S:1515 E:1518 ||| NNP
) ||| S:1518 E:1519 ||| -RRB-
,  ||| S:1519 E:1521 ||| ,
nonprotein  ||| S:1521 E:1532 ||| FW
sulfhydryl  ||| S:1532 E:1543 ||| FW
( ||| S:1543 E:1544 ||| -LRB-
NPSH ||| S:1544 E:1548 ||| NNP
)  ||| S:1548 E:1550 ||| -RRB-
and  ||| S:1550 E:1554 ||| CC
total  ||| S:1554 E:1560 ||| JJ
bilirubin  ||| S:1560 E:1570 ||| NN
in  ||| S:1570 E:1573 ||| IN
serum  ||| S:1573 E:1579 ||| NN
after  ||| S:1579 E:1585 ||| IN
6  ||| S:1585 E:1587 ||| CD
h  ||| S:1587 E:1589 ||| CD
EtOH  ||| S:1589 E:1594 ||| JJ
administration ||| S:1594 E:1608 ||| NN
.  ||| S:1608 E:1610 ||| .
These  ||| S:1610 E:1616 ||| DT
levels  ||| S:1616 E:1623 ||| NNS
were  ||| S:1623 E:1628 ||| VBD
progressively  ||| S:1628 E:1642 ||| RB
decreased  ||| S:1642 E:1652 ||| VBN
over  ||| S:1652 E:1657 ||| IN
168  ||| S:1657 E:1661 ||| CD
h ||| S:1661 E:1662 ||| NNS
.  ||| S:1662 E:1664 ||| .
Total  ||| S:1664 E:1670 ||| JJ
protein  ||| S:1670 E:1678 ||| NN
and  ||| S:1678 E:1682 ||| CC
albumin  ||| S:1682 E:1690 ||| NNS
were  ||| S:1690 E:1695 ||| VBD
reduced  ||| S:1695 E:1703 ||| VBN
in  ||| S:1703 E:1706 ||| IN
serum  ||| S:1706 E:1712 ||| NN
after  ||| S:1712 E:1718 ||| IN
6  ||| S:1718 E:1720 ||| CD
h  ||| S:1720 E:1722 ||| JJ
administration  ||| S:1722 E:1737 ||| NN
and  ||| S:1737 E:1741 ||| CC
then  ||| S:1741 E:1746 ||| RB
progressively  ||| S:1746 E:1760 ||| RB
increased ||| S:1760 E:1769 ||| VBN
.  ||| S:1769 E:1771 ||| .
In  ||| S:1771 E:1774 ||| IN
contrast ||| S:1774 E:1782 ||| NN
,  ||| S:1782 E:1784 ||| ,
tissues  ||| S:1784 E:1792 ||| JJ
disorder  ||| S:1792 E:1801 ||| NN
histology  ||| S:1801 E:1811 ||| NNS
and  ||| S:1811 E:1815 ||| CC
morphology  ||| S:1815 E:1826 ||| NNS
were  ||| S:1826 E:1831 ||| VBD
determined  ||| S:1831 E:1842 ||| VBN
in  ||| S:1842 E:1845 ||| IN
liver  ||| S:1845 E:1851 ||| JJ
sections ||| S:1851 E:1859 ||| NNS
.  ||| S:1859 E:1861 ||| .
After  ||| S:1861 E:1867 ||| IN
rats  ||| S:1867 E:1872 ||| NNS
were  ||| S:1872 E:1877 ||| VBD
fed  ||| S:1877 E:1881 ||| VBN
TCMs  ||| S:1881 E:1886 ||| JJ
we  ||| S:1886 E:1889 ||| PRP
found  ||| S:1889 E:1895 ||| VBD
that  ||| S:1895 E:1900 ||| IN
SMB  ||| S:1900 E:1904 ||| NNP
extraction  ||| S:1904 E:1915 ||| VBD
not  ||| S:1915 E:1919 ||| RB
only  ||| S:1919 E:1924 ||| RB
induced  ||| S:1924 E:1932 ||| VBN
HGF ||| S:1932 E:1935 ||| NNP
,  ||| S:1935 E:1937 ||| ,
FAK ||| S:1937 E:1940 ||| NNP
,  ||| S:1940 E:1942 ||| ,
Cyclin  ||| S:1942 E:1949 ||| NNP
D1 ||| S:1949 E:1951 ||| NNP
,  ||| S:1951 E:1953 ||| ,
and  ||| S:1953 E:1957 ||| CC
pRb  ||| S:1957 E:1961 ||| JJ
protein  ||| S:1961 E:1969 ||| NN
expression  ||| S:1969 E:1980 ||| NN
and  ||| S:1980 E:1984 ||| CC
Cyclin  ||| S:1984 E:1991 ||| NNP
D1  ||| S:1991 E:1994 ||| NNP
mRNA  ||| S:1994 E:1999 ||| JJ
increases ||| S:1999 E:2008 ||| NNS
,  ||| S:2008 E:2010 ||| ,
but  ||| S:2010 E:2014 ||| CC
also  ||| S:2014 E:2019 ||| RB
reduced  ||| S:2019 E:2027 ||| VBN
MMP-2  ||| S:2027 E:2033 ||| NNP
and  ||| S:2033 E:2037 ||| CC
MMP-9  ||| S:2037 E:2043 ||| CD
after  ||| S:2043 E:2049 ||| IN
24  ||| S:2049 E:2052 ||| CD
and  ||| S:2052 E:2056 ||| CC
72  ||| S:2056 E:2059 ||| CD
h  ||| S:2059 E:2061 ||| JJ
post  ||| S:2061 E:2066 ||| NN
injury ||| S:2066 E:2072 ||| NN
.  ||| S:2072 E:2074 ||| .
In  ||| S:2074 E:2077 ||| IN
the  ||| S:2077 E:2081 ||| DT
cell  ||| S:2081 E:2086 ||| NN
cycle  ||| S:2086 E:2092 ||| NN
S  ||| S:2092 E:2094 ||| NNP
phase  ||| S:2094 E:2100 ||| VBD
the  ||| S:2100 E:2104 ||| DT
Cyclin  ||| S:2104 E:2111 ||| NNP
E  ||| S:2111 E:2113 ||| NNP
protein  ||| S:2113 E:2121 ||| NN
expression  ||| S:2121 E:2132 ||| NN
was  ||| S:2132 E:2136 ||| VBD
increased  ||| S:2136 E:2146 ||| VBN
by  ||| S:2146 E:2149 ||| IN
ESL ||| S:2149 E:2152 ||| NNP
.  ||| S:2152 E:2154 ||| .
CP  ||| S:2154 E:2157 ||| NNP
induced  ||| S:2157 E:2165 ||| VBD
TIMP-1 ||| S:2165 E:2171 ||| CD
,  ||| S:2171 E:2173 ||| ,
TIMP-2  ||| S:2173 E:2180 ||| NNP
and  ||| S:2180 E:2184 ||| CC
TIMP-3  ||| S:2184 E:2191 ||| CD
mRNA  ||| S:2191 E:2196 ||| JJ
increases  ||| S:2196 E:2206 ||| NNS
in  ||| S:2206 E:2209 ||| IN
fibrotic  ||| S:2209 E:2218 ||| JJ
rats ||| S:2218 E:2222 ||| NNS
.  ||| S:2222 E:2224 ||| .
We  ||| S:2224 E:2227 ||| PRP
detected  ||| S:2227 E:2236 ||| VBD
liver  ||| S:2236 E:2242 ||| JJ
regeneration  ||| S:2242 E:2255 ||| NN
in  ||| S:2255 E:2258 ||| IN
fibrotic  ||| S:2258 E:2267 ||| JJ
rats ||| S:2267 E:2271 ||| NNS
.  ||| S:2271 E:2273 ||| .
We  ||| S:2273 E:2276 ||| PRP
also  ||| S:2276 E:2281 ||| RB
found  ||| S:2281 E:2287 ||| VBN
that  ||| S:2287 E:2292 ||| IN
the  ||| S:2292 E:2296 ||| DT
liver  ||| S:2296 E:2302 ||| JJ
regeneration  ||| S:2302 E:2315 ||| JJ
index  ||| S:2315 E:2321 ||| NN
increased  ||| S:2321 E:2331 ||| VBN
from  ||| S:2331 E:2336 ||| IN
6  ||| S:2336 E:2338 ||| CD
to  ||| S:2338 E:2341 ||| TO
168  ||| S:2341 E:2345 ||| CD
h  ||| S:2345 E:2347 ||| JJ
post  ||| S:2347 E:2352 ||| NN
PHx ||| S:2352 E:2355 ||| NN
.  ||| S:2355 E:2357 ||| .
After  ||| S:2357 E:2363 ||| IN
168  ||| S:2363 E:2367 ||| CD
h  ||| S:2367 E:2369 ||| FW
fibrotic  ||| S:2369 E:2378 ||| FW
liver  ||| S:2378 E:2384 ||| FW
regeneration  ||| S:2384 E:2397 ||| FW
rats  ||| S:2397 E:2402 ||| FW
exhibited  ||| S:2402 E:2412 ||| FW
reduced  ||| S:2412 E:2420 ||| FW
TGF-β1  ||| S:2420 E:2427 ||| FW
mRNA  ||| S:2427 E:2432 ||| JJ
expression  ||| S:2432 E:2443 ||| NN
and  ||| S:2443 E:2447 ||| CC
enhanced  ||| S:2447 E:2456 ||| JJ
Cyclin  ||| S:2456 E:2463 ||| NNP
D1 ||| S:2463 E:2465 ||| NNP
,  ||| S:2465 E:2467 ||| ,
Cyclin  ||| S:2467 E:2474 ||| NNP
E ||| S:2474 E:2475 ||| NNP
,  ||| S:2475 E:2477 ||| ,
pRb  ||| S:2477 E:2481 ||| JJ
and  ||| S:2481 E:2485 ||| CC
E2F  ||| S:2485 E:2489 ||| CD
mRNA  ||| S:2489 E:2494 ||| JJ
expression ||| S:2494 E:2504 ||| NN
.  ||| S:2504 E:2506 ||| .
TCMs  ||| S:2506 E:2511 ||| JJ
play  ||| S:2511 E:2516 ||| NN
a  ||| S:2516 E:2518 ||| DT
crucial  ||| S:2518 E:2526 ||| JJ
role  ||| S:2526 E:2531 ||| NN
in  ||| S:2531 E:2534 ||| IN
the  ||| S:2534 E:2538 ||| DT
early  ||| S:2538 E:2544 ||| JJ
mediating  ||| S:2544 E:2554 ||| JJ
process  ||| S:2554 E:2562 ||| NN
in  ||| S:2562 E:2565 ||| IN
fibrotic  ||| S:2565 E:2574 ||| JJ
rat  ||| S:2574 E:2578 ||| NN
liver  ||| S:2578 E:2584 ||| NN
regeneration  ||| S:2584 E:2597 ||| NN
after  ||| S:2597 E:2603 ||| IN
PHx ||| S:2603 E:2606 ||| JJ
.  ||| S:2606 E:2608 ||| .
